Invasive pneumococcal disease caused by ceftriaxone-resistant Streptococcus pneumoniae in Taiwan

Iroh Tam, 2014, Invasive pneumococcal disease after implementation of 13-valent conjugate vaccine, Pediatrics, 134, 210, 10.1542/peds.2014-0473 Hsieh, 2009, National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential, Vaccine, 27, 5513, 10.1016/j.vaccine.2009.06.091 Rajaratnam, 2010, Neonatal, postneonatal, childhood, and under-5 mortality for 187 countries, 1970–2010: a systematic analysis of progress towards Millennium Development Goal 4, Lancet, 375, 1988, 10.1016/S0140-6736(10)60703-9 Black, 2010, Global, regional, and national causes of child mortality in 2008: a systematic analysis, Lancet, 375, 1969, 10.1016/S0140-6736(10)60549-1 Su, 2015, Evolving pneumococcal serotypes and sequence types in relation to high antibiotic stress and conditional pneumococcal immunization, Sci Rep, 5, 15843, 10.1038/srep15843 Chiu, 2007, Increasing ceftriaxone resistance and multiple alterations of penicillin-binding proteins among penicillin-resistant Streptococcus pneumoniae isolates in Taiwan, Antimicrob Agents Chemother, 51, 3404, 10.1128/AAC.01563-06 Mavroidi, 2007, Spread of the Streptococcus pneumoniae Taiwan19F-14 clone among children in Greece, Clin Microbiol Infect, 13, 1213, 10.1111/j.1469-0691.2007.01837.x Dicuonzo, 2002, Genotypes of invasive pneumococcal isolates recently recovered from Italian patients, J Clin Microbiol, 40, 3660, 10.1128/JCM.40.10.3660-3665.2002 Wolter, 2008, Molecular basis and clonal nature of increasing pneumococcal macrolide resistance in South Africa, 2000–2005, Int J Antimicrob Agents, 32, 62, 10.1016/j.ijantimicag.2008.01.013 Bean, 2005, Characterization of major clones of antibiotic-resistant Streptococcus pneumoniae in New Zealand by multilocus sequence typing, J Antimicrob Chemother, 55, 375, 10.1093/jac/dki001 Wei, 2015, Pediatric invasive pneumococcal disease in Taiwan following a national catch-up program with the 13-valent pneumococcal conjugate vaccine, Pediatr Infect Dis J, 34, e71, 10.1097/INF.0000000000000565 Chiang, 2014, National surveillance of invasive pneumococcal diseases in Taiwan, 2008–2012: differential temporal emergence of serotype 19A, Vaccine, 32, 3345, 10.1016/j.vaccine.2014.04.061 Liao, 2010, Impact of pneumococcal vaccines on invasive pneumococcal disease in Taiwan, Eur J Clin Microbiol Infect Dis, 29, 489, 10.1007/s10096-010-0873-7 Janapatla, 2010, Sequence types and antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates from a region with high antibiotic selective pressure and suboptimal vaccine coverage, Pediatr Infect Dis J, 29, 467, 10.1097/INF.0b013e3181cb45f3 Shin, 2011, Predominance of ST320 among Streptococcus pneumoniae serotype 19A isolates from 10 Asian countries, J Antimicrob Chemother, 66, 1001, 10.1093/jac/dkr048 Choi, 2008, Streptococcus pneumoniae serotype 19A in children, South Korea, Emerg Infect Dis, 14, 275, 10.3201/eid1402.070807 Jolley, 2015, Validation and optimisation of an ICD-10-coded case definition for sepsis using administrative health data, BMJ Open, 5, 10.1136/bmjopen-2015-009487 Hsieh, 2011, Necrotizing pneumococcal pneumonia with bronchopleural fistula among children in Taiwan, Pediatr Infect Dis J, 30, 740, 10.1097/INF.0b013e31821b10c3 Singer, 2016, The third international consensus definitions for sepsis and septic shock (Sepsis-3), JAMA, 315, 801, 10.1001/jama.2016.0287 Lee, 2014, Risk factors and outcome analysis of Acinetobacter baumannii complex bacteremia in critical patients, Crit Care Med, 42, 1081, 10.1097/CCM.0000000000000125 Lee, 2015, Impact of molecular epidemiology and reduced susceptibility to glycopeptides and daptomycin on outcomes of patients with methicillin-resistant Staphylococcus aureus Bacteremia, PLoS One, 10 Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 Garner, 1988, CDC definitions for nosocomial infections, Am J Infect Control, 16, 128, 10.1016/0196-6553(88)90053-3 Clinical and Laboratory Standards Institute, 2015 Pai, 2006, Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates, J Clin Microbiol, 44, 124, 10.1128/JCM.44.1.124-131.2006 Jin, 2009, First report of putative Streptococcus pneumoniae serotype 6D among nasopharyngeal isolates from Fijian children, J Infect Dis, 200, 1375, 10.1086/606118 Yun, 2011, Streptococcus pneumoniae type determination by multiplex polymerase chain reaction, J Korean Med Sci, 26, 971, 10.3346/jkms.2011.26.8.971 Kim, 2012, Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study, Antimicrob Agents Chemother, 56, 1418, 10.1128/AAC.05658-11 Isaacman, 2010, Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines, Int J Infect Dis, 14, e197, 10.1016/j.ijid.2009.05.010 von Mollendorf, 2014, Factors associated with ceftriaxone nonsusceptibility of Streptococcus pneumoniae: analysis of South African national surveillance data, 2003 to 2010, Antimicrob Agents Chemother, 58, 3293, 10.1128/AAC.02580-13 Mendes, 2014, Decreased ceftriaxone susceptibility in emerging (35B and 6C) and persisting (19A) Streptococcus pneumoniae serotypes in the United States, 2011–2012: ceftaroline remains active in vitro among β-lactam agents, Antimicrob Agents Chemother, 58, 4923, 10.1128/AAC.02976-14 Aspa, 2008, Pneumococcal antimicrobial resistance: therapeutic strategy and management in community-acquired pneumonia, Expert Opin Pharmacother, 9, 229, 10.1517/14656566.9.2.229 Van Bambeke, 2007, Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options, Drugs, 67, 2355, 10.2165/00003495-200767160-00005 Chiou, 2006, Severe pneumococcal pneumonia: new strategies for management, Curr Opin Crit Care, 12, 470 Tsai, 2013, Trends in the antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae: results from the Tigecycline In vitro Surveillance in Taiwan (TIST) study, 2006–2010, Int J Antimicrob Agents, 42, 312, 10.1016/j.ijantimicag.2013.05.013 Wei, 2015, Pneumococcal disease and use of pneumococcal vaccines in Taiwan, Clin Exp Vaccine Res, 4, 121, 10.7774/cevr.2015.4.2.121 Su, 2009, Antimicrobial susceptibility of Streptococcus pneumoniae at a university hospital in Taiwan, 2000–07: impact of modified non-meningeal penicillin breakpoints in CLSI M100-S18, J Antimicrob Chemother, 64, 336, 10.1093/jac/dkp209 Lee, 2013, Capsular serotypes and antimicrobial susceptibilities of Streptococcus pneumoniae causing invasive pneumococcal disease from 2009–2012 with an emphasis on serotype 19A in bacteraemic pneumonia and empyema and β-lactam resistance, Int J Antimicrob Agents, 42, 395, 10.1016/j.ijantimicag.2013.07.017 Shi, 1998, Identification of three major clones of multiply antibiotic-resistant Streptococcus pneumoniae in Taiwanese hospitals by multilocus sequence typing, J Clin Microbiol, 36, 3514, 10.1128/JCM.36.12.3514-3519.1998